Callan Family Office »

ADC Therapeutics SA shares owned by Callan Family Office

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Callan Family Office from 13F filings

Historical chart of Callan Family Office investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Callan Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Callan Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $84k 24k 3.53

More positions owned by Callan Family Office

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Scottsdale Fds Vng Rus3000idx (VTHR)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Ishares Tr Rus 1000 Grw Etf (IWF)
Visa Com Cl A (V)

View all positions for Callan Family Office

Top funds holding ADC Therapeutics SA

Redmile Group
TCG Crossover Management
Prosight Management
OrbiMed Advisors
Nantahala Capital Management
BlackRock
Point72 Asset Management
Eventide Asset Management
Goldman Sachs Group
State Street Corporation
Vanguard Group
Geode Capital Management
Platinum Investment Mangement
Bnp Paribas Arbitrage, Snc
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA